Altered N6-Methyladenosine Modification Patterns and Transcript Profiles Contributes to Cognitive Dysfunction in...

Area of Science:

• Neuroscience
• Epigenetics
• Molecular Biology

Background:

• N6-methyladenosine (m⁶A) is a crucial mRNA modification in eukaryotes.
• m⁶A is dynamically regulated in the mammalian central nervous system by various stimuli.
• The role of m⁶A in the hippocampus during diabetes cognitive impairment (DCI) remains unexplored.

Purpose of the Study:

• To investigate the m⁶A methylation landscape in the hippocampus of a DCI mouse model.
• To identify differentially m⁶A-modified and expressed genes in DCI.
• To elucidate the underlying regulatory mechanisms of m⁶A in DCI.

Main Methods:

• Established a DCI mouse model using a high-fat diet.
• Performed m⁶A-immunoprecipitation sequencing (m⁶A-IP-Seq) and RNA sequencing on hippocampal tissue.
• Analyzed differentially modified and expressed genes and enriched pathways.

Main Results:

• Identified significant alterations in m⁶A methylation patterns in the DCI mouse hippocampus.
• Found differentially expressed genes enriched in synaptic transmission and axonal guidance pathways.
• Observed changes in the expression of key m⁶A regulators, including METTL3, METTL14, and FTO.

Conclusions:

• m⁶A modification is significantly altered in the hippocampus during DCI.
• Altered m⁶A patterns impact neuronal function, specifically synaptic transmission and axonal guidance.
• These findings suggest a novel RNA-based epigenetic regulatory mechanism in DCI, offering potential therapeutic avenues.